Modelling-filtered drug repurposing and first-in-protein SPR validation of histone deacetylase 4 inhibitors for Ataxia-telangiectasia
Open Access
- 4 October 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 192, 118621
Abstract
No abstract availableKeywords
Funding Information
- Ministero della Salute (CUP E63C22001680001\u2014ID T4-AN-04)
This publication has 29 references indexed in Scilit:
- Molecular medicinal insights into scaffold hopping-based drug discovery successDrug Discovery Today, 2023
- Identification of a novel adiponectin receptor and opioid receptor dual acting agonist as a potential treatment for diabetic neuropathyBiomedicine & Pharmacotherapy, 2022
- An SPR-based method for Hill coefficient measurements: the case of insulin-degrading enzymeAnalytical and Bioanalytical Chemistry, 2022
- Assessment of Binding Affinity via Alchemical Free-Energy CalculationsJournal of Chemical Information and Modeling, 2020
- Microfluidic networks for surface plasmon resonance imaging real-time kinetics experimentsMicrochemical Journal, 2009
- Histone deacetylase inhibitors: Potential in cancer therapyJournal of Cellular Biochemistry, 2009
- Enzyme solid-state support assays: a surface plasmon resonance and mass spectrometry coupled study of immobilized insulin degrading enzymeEuropean Biophysics Journal, 2008
- Converging free energy estimates: MM‐PB(GB)SA studies on the protein–protein complex Ras–RafJournal of Computational Chemistry, 2003
- Class II histone deacetylases: versatile regulatorsTrends in Genetics, 2003
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997